Establishment of mouse model of inherited PIGO deficiency and therapeutic potential of AAV-based gene therapy.
Establishment of mouse model of inherited PIGO deficiency and therapeutic potential of AAV-based gene therapy.
复制标题
DOI:
10.1038/s41467-022-30847-x
复制
发表时间:
2022-06-03
影响因子:
16.6
通讯作者:
中科院分区:
文献类型:
--
作者:
Inherited glycosylphosphatidylinositol (GPI) deficiency (IGD) is caused by mutations in GPI biosynthesis genes. The mechanisms of its systemic, especially neurological, symptoms are not clarified and fundamental therapy has not been established. Here, we report establishment of mouse models of IGD caused by PIGO mutations as well as development of effective gene therapy. As the clinical manifestations of IGD are systemic and lifelong lasting, we treated the mice with adeno-associated virus for homology-independent knock-in as well as extra-chromosomal expression of Pigo cDNA. Significant amelioration of neuronal phenotypes and growth defect was achieved, opening a new avenue for curing IGDs. Inherited GPI deficiency (IGD) is caused by PIGO mutations. Here, the authors generate a mouse model of IGD and show that AAV-mediate gene therapy, for knock-in as well as extra-chromosomal expression of Pigo cDNA, ameliorates pathology in the mice.
登录
查看更多内容
影响因子:
20.3
作者:
Kawagoe, K;Kitamura, D;Takeda, J
通讯作者:
Takeda, J
影响因子:
25
作者:
Chan KY;Jang MJ;Yoo BB;Greenbaum A;Ravi N;Wu WL;Sánchez-Guardado L;Lois C;Mazmanian SK;Deverman BE;Gradinaru V
通讯作者:
Gradinaru V
影响因子:
14.5
作者:
Kojima, Karin;Nakajima, Takeshi;Yamagata, Takanori
通讯作者:
Yamagata, Takanori
影响因子:
4.5
作者:
Loughner CL;Bruford EA;McAndrews MS;Delp EE;Swamynathan S;Swamynathan SK
通讯作者:
Swamynathan SK
影响因子:
30.8
作者:
Krawitz, Peter M.;Schweiger, Michal R.;Robinson, Peter N.
通讯作者:
Robinson, Peter N.